Pharmaceutical Manufacturing is Witnessing Major Transformation as New Demands for Sterility Assurance Reshape Healthcare

 

For an industry where precision and quality control are paramount, pharmaceutical manufacturing is witnessing an evolutionary leap in contamination control practices. Propelled by changes in regulatory environments, such as the EU’s Annex 1 update and ICH Q9 focusing on quality risk management, the sector is shifting from isolated, data-point-centric strategies towards a more holistic approach. 

This transformation emphasizes the integration of various operational elements – from facility design to process controls – under a single, strategic umbrella of sterility assurance. As this shift towards comprehensive, AI and machine learning assisted processes reshapes the pharmaceutical manufacturing industry. Exploring this on “Exceeding Your Benchmark,” a podcast by Benchmark Products, is Fred Ayers. The Advisor for Sterility Assurance for Global Quality Systems at Eli Lilly is an industry expert, and shared some of his insights as he’s been at the forefront of this change.

 

Recent Episodes

Virtual care is no longer an experiment—it’s a structural shift in healthcare. Telehealth usage remains significantly higher than pre-2020 levels, and providers across disciplines are rethinking how to deliver higher-quality outcomes without the overhead and insurance constraints of traditional clinics. Meanwhile, recreational and endurance sports participation continues to rise, with millions of Americans registering…

Hospitals and surgery centers own millions of dollars in equipment — but owning assets and having actionable visibility into them are two different things. Most systems maintain inventories, yet many struggle with outdated records, fragmented tracking, and limited insight into useful life or service contracts. With nearly half of U.S. hospitals reporting negative operating…

Behind every city vote, hospital budget or zoning decision is a leader navigating tough, often conflicting priorities. Right now, public leaders are operating in an environment of rising healthcare costs, workforce shortages and heightened community expectations—especially within safety-net systems that collectively provide billions in uncompensated care each year. The stakes are real—they affect patients…